AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Y-mAbs Therapeutics Inc. (YMAB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

6.18

-0.01 (-0.16%)

At close: Jan 22, 2025, 3:59 PM

6.19

0.08%

After-hours Jan 22, 2025, 04:41 PM EST

Y-mAbs Therapeutics Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
License Revenue	500.00K	500.00K	63.57M	20.75M	15.00M	0	1.00M	0	0	2.00M	0
License Revenue Growth	0.00%	-99.21%	+206.34%	+38.34%	n/a	-100.00%	n/a	n/a	-100.00%	n/a	n/a
Product Revenue	18.46M	19.43M	n/a	n/a	16.45M	12.54M	9.80M	9.60M	8.96M	8.95M	5.38M
Product Revenue Growth	-4.99%	n/a	n/a	n/a	+31.19%	+27.97%	+2.07%	+7.06%	+0.16%	+66.28%	n/a

Revenue by Geography

Quarter	Dec 31, 2023
Non-Us Revenue	16.50M
Non-Us Revenue Growth	n/a
United States Revenue	67.81M
United States Revenue Growth	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Selling, General, and Administrative Revenue	13.61M	17.23M	11.43M	11.13M	10.20M	11.27M	12.25M	10.79M	13.63M	23.08M	13.44M	15.14M	13.99M	13.47M	11.97M	14.63M	11.64M	10.39M	8.13M	6.93M	4.70M	4.14M	3.74M	3.04M	2.68M	1.97M	1.27M	2.65M	766.00K	760.50K	760.50K
Selling, General, and Administrative Revenue Growth	-21.00%	+50.83%	+2.60%	+9.17%	-9.49%	-8.01%	+13.51%	-20.79%	-40.97%	+71.77%	-11.23%	+8.22%	+3.81%	+12.57%	-18.18%	+25.73%	+11.96%	+27.91%	+17.23%	+47.50%	+13.50%	+10.64%	+23.21%	+13.15%	+36.59%	+54.12%	-51.89%	+245.95%	+0.72%	n/a	n/a
Research and Development Revenue	11.17M	12.34M	13.27M	13.39M	15.36M	12.05M	13.42M	19.79M	22.45M	26.42M	22.91M	28.76M	23.13M	19.78M	21.58M	24.01M	21.00M	30.06M	18.62M	16.83M	19.66M	14.49M	12.51M	11.04M	8.73M	8.29M	6.20M	6.63M	3.08M	2.30M	2.30M
Research and Development Revenue Growth	-9.50%	-6.98%	-0.90%	-12.83%	+27.40%	-10.16%	-32.19%	-11.87%	-15.02%	+15.31%	-20.33%	+24.32%	+16.95%	-8.35%	-10.13%	+14.31%	-30.12%	+61.42%	+10.67%	-14.41%	+35.64%	+15.85%	+13.31%	+26.46%	+5.28%	+33.67%	-6.35%	+115.38%	+33.56%	n/a	n/a